FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154642413> ?p ?o ?g. }

• W2154642413 endingPage "11066" @default.
• W2154642413 startingPage "11056" @default.
• W2154642413 abstract "Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. IL-6 is a multifunctional cytokine that is associated with the disease status and outcomes of cancers. However, the effect of IL-6 on the migration activity of human chondrosarcoma cells is mostly unknown. Here, we found that IL-6 increased the migration and expression of MMP-13 in human chondrosarcoma cells. We also found that human chondrosarcoma tissues had significant expression of IL-6, which was higher than that in normal cartilage. IL-6-mediated migration and MMP-13 up-regulation were attenuated by anti-IL-6 receptor antibody, Ras, Raf-1, and a MEK inhibitor. Activation of the Ras, Raf-1, MEK, ERK, and NF-κB signaling pathways after IL-6 treatment was demonstrated, and IL-6-induced MMP-13 expression and migration activity were inhibited by the specific inhibitor and mutant Ras, Raf-1, MEK, ERK, and NF-κB cascades. In addition, migration-prone sublines demonstrated that cells with increasing migration ability had greater expression of IL-6 and MMP-13. Taken together, these results indicate that IL-6 and IL-6 receptor interaction enhances migration of chondrosarcoma through an increase in MMP-13 production. Chondrosarcoma is a type of highly malignant tumor with a potent capacity to invade locally and cause distant metastasis. Chondrosarcoma shows a predilection for metastasis to the lungs. IL-6 is a multifunctional cytokine that is associated with the disease status and outcomes of cancers. However, the effect of IL-6 on the migration activity of human chondrosarcoma cells is mostly unknown. Here, we found that IL-6 increased the migration and expression of MMP-13 in human chondrosarcoma cells. We also found that human chondrosarcoma tissues had significant expression of IL-6, which was higher than that in normal cartilage. IL-6-mediated migration and MMP-13 up-regulation were attenuated by anti-IL-6 receptor antibody, Ras, Raf-1, and a MEK inhibitor. Activation of the Ras, Raf-1, MEK, ERK, and NF-κB signaling pathways after IL-6 treatment was demonstrated, and IL-6-induced MMP-13 expression and migration activity were inhibited by the specific inhibitor and mutant Ras, Raf-1, MEK, ERK, and NF-κB cascades. In addition, migration-prone sublines demonstrated that cells with increasing migration ability had greater expression of IL-6 and MMP-13. Taken together, these results indicate that IL-6 and IL-6 receptor interaction enhances migration of chondrosarcoma through an increase in MMP-13 production." @default.
• W2154642413 created "2016-06-24" @default.
• W2154642413 creator A5012428737 @default.
• W2154642413 creator A5065538162 @default.
• W2154642413 creator A5076096342 @default.
• W2154642413 creator A5085507861 @default.
• W2154642413 date "2011-04-01" @default.
• W2154642413 modified "2023-10-11" @default.
• W2154642413 title "IL-6 Increases MMP-13 Expression and Motility in Human Chondrosarcoma Cells" @default.
• W2154642413 cites W1590871522 @default.
• W2154642413 cites W1965072143 @default.
• W2154642413 cites W1966948292 @default.
• W2154642413 cites W1968790357 @default.
• W2154642413 cites W1973452897 @default.
• W2154642413 cites W1974091059 @default.
• W2154642413 cites W1980302606 @default.
• W2154642413 cites W1989578744 @default.
• W2154642413 cites W1990898347 @default.
• W2154642413 cites W1991280418 @default.
• W2154642413 cites W1993163893 @default.
• W2154642413 cites W1995541297 @default.
• W2154642413 cites W2003500892 @default.
• W2154642413 cites W2030838406 @default.
• W2154642413 cites W2033100064 @default.
• W2154642413 cites W2036285327 @default.
• W2154642413 cites W2038036973 @default.
• W2154642413 cites W2038227634 @default.
• W2154642413 cites W2044719350 @default.
• W2154642413 cites W2051971925 @default.
• W2154642413 cites W2058554371 @default.
• W2154642413 cites W2058557113 @default.
• W2154642413 cites W2060557536 @default.
• W2154642413 cites W2061628667 @default.
• W2154642413 cites W2062265555 @default.
• W2154642413 cites W2063295519 @default.
• W2154642413 cites W2068032848 @default.
• W2154642413 cites W2073402472 @default.
• W2154642413 cites W2075760937 @default.
• W2154642413 cites W2085931606 @default.
• W2154642413 cites W2095920344 @default.
• W2154642413 cites W2101596544 @default.
• W2154642413 cites W2114429963 @default.
• W2154642413 cites W2120858407 @default.
• W2154642413 cites W2134546428 @default.
• W2154642413 cites W2135945960 @default.
• W2154642413 cites W2143442755 @default.
• W2154642413 cites W2158657686 @default.
• W2154642413 cites W2160648771 @default.
• W2154642413 cites W4243003607 @default.
• W2154642413 cites W4255941290 @default.
• W2154642413 cites W4376848667 @default.
• W2154642413 doi "https://doi.org/10.1074/jbc.m110.204081" @default.
• W2154642413 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3064160" @default.
• W2154642413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21278254" @default.
• W2154642413 hasPublicationYear "2011" @default.
• W2154642413 type Work @default.
• W2154642413 sameAs 2154642413 @default.
• W2154642413 citedByCount "41" @default.
• W2154642413 countsByYear W21546424132012 @default.
• W2154642413 countsByYear W21546424132013 @default.
• W2154642413 countsByYear W21546424132014 @default.
• W2154642413 countsByYear W21546424132015 @default.
• W2154642413 countsByYear W21546424132016 @default.
• W2154642413 countsByYear W21546424132017 @default.
• W2154642413 countsByYear W21546424132018 @default.
• W2154642413 countsByYear W21546424132019 @default.
• W2154642413 countsByYear W21546424132020 @default.
• W2154642413 countsByYear W21546424132021 @default.
• W2154642413 countsByYear W21546424132022 @default.
• W2154642413 crossrefType "journal-article" @default.
• W2154642413 hasAuthorship W2154642413A5012428737 @default.
• W2154642413 hasAuthorship W2154642413A5065538162 @default.
• W2154642413 hasAuthorship W2154642413A5076096342 @default.
• W2154642413 hasAuthorship W2154642413A5085507861 @default.
• W2154642413 hasBestOaLocation W21546424131 @default.
• W2154642413 hasConcept C105702510 @default.
• W2154642413 hasConcept C109523444 @default.
• W2154642413 hasConcept C121608353 @default.
• W2154642413 hasConcept C126322002 @default.
• W2154642413 hasConcept C142724271 @default.
• W2154642413 hasConcept C203014093 @default.
• W2154642413 hasConcept C2776302905 @default.
• W2154642413 hasConcept C2778690821 @default.
• W2154642413 hasConcept C2779013556 @default.
• W2154642413 hasConcept C2780550940 @default.
• W2154642413 hasConcept C502942594 @default.
• W2154642413 hasConcept C57074206 @default.
• W2154642413 hasConcept C58207958 @default.
• W2154642413 hasConcept C62478195 @default.
• W2154642413 hasConcept C71924100 @default.
• W2154642413 hasConcept C86803240 @default.
• W2154642413 hasConcept C95444343 @default.
• W2154642413 hasConceptScore W2154642413C105702510 @default.
• W2154642413 hasConceptScore W2154642413C109523444 @default.
• W2154642413 hasConceptScore W2154642413C121608353 @default.
• W2154642413 hasConceptScore W2154642413C126322002 @default.
• W2154642413 hasConceptScore W2154642413C142724271 @default.
• W2154642413 hasConceptScore W2154642413C203014093 @default.

• next